Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?

Abstract EN

Background.

Gastric varices (GV) are associated with high morbidity and mortality in patients with portal hypertension.

Endoscopic cyanoacrylate injection is the first-line recommended therapy for GV obliteration.

This study aims to explore the reason behind related adverse events and better prevent its occurrence.

Methods.

A retrospective case series study was conducted from January 1, 2013, to December 31, 2016, to identify patients who experienced severe adverse events secondary to endoscopic cyanoacrylate injection.

A literature review of similar cases was performed on two medical databases, Medline and Embase.

Results.

A total of 652 patients underwent cyanoacrylate injection at our center within the study duration.

Five cases of severe adverse events related to the use of tissue adhesives were identified.

Detailed clinical presentation, patient treatment, and outcomes were reviewed and analyzed.

Twenty-seven similar cases were identified based on the literature review providing further insight into the study.

Conclusion.

Although rare in incidence, systemic embolism associated with cyanoacrylate injection is often fatal or debilitating.

This report may raise awareness in treatment protocol, including the necessity of preoperative angiographic studies, to avoid similar adverse events in clinical practice.